70511-162Level 3
Bortezomib (bortezomib)
**Product type:** Human Prescription Drug
**Active ingredient:** BORTEZOMIB
**Strength:** 2.5 mg/1
**Dosage form:** Injection
**Route:** Intravenous
**Labeler:** MAIA Pharmaceuticals, Inc.
**Marketing category:** NDA (NDA215331)
**Pharmacologic class:** Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/70511-162Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.